Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Growing abroad
August 2019
SHARING OPTIONS:

BUFFALO, N.Y.—Athenex Inc. has launched strategic global initiatives in order to grow its European and Latin American presence and expand its global clinical research and development capacity. In keeping with these efforts, Athenex has established a subsidiary in the U.K., with offices in Manchester, and will continue to grow its R&D capacity in the area. In Latin America, the company recently announced a definitive agreement under which it will acquire certain assets from CIDAL Limited in exchange for shares of Athenex common stock.
 
“These initiatives represent an important step in our ongoing strategic efforts to expand our clinical research and operations for global development, with the potential for increased clinical research efficiencies and cost-effectiveness … We believe having a stronger presence in these territories will position us well to evaluate new R&D and commercialization opportunities in Europe and Latin America,” remarked Dr. Johnson Lau, chairman and CEO of Athenex.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.